PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'PharmBioTec GmbH, Saarbrücken, Germany.\', \'Department of Pharmacy, Saarland University, Saarbrücken, Germany.\', \'Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Saarbrücken, Germany.\', \'Croston Consulting, San Diego, CA, USA.\', \'Department of Non-Clinical Development, 211190Ferring Pharmaceuticals A/S, Copenhagen, Denmark.\', \'3RProducts Marius Hittinger, Blieskastel, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1177/0261192920983015
?:doi
?:hasPublicationType
?:journal
  • Alternatives to laboratory animals : ATLA
is ?:pmid of
?:pmid
?:pmid
  • 33513307
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Modulating the Barrier Function of Human Alveolar Epithelial (hAELVi) Cell Monolayers as a Model of Inflammation.
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33513307>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33513307>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all